An Arizona man has been sitting on death row for two decades. He asked to be executed next month
An Arizona man has been sitting on death row for two decades. He asked to be executed next month - An Arizona death row ...
The American Journal of Managed Care3d
FDA Approves First Subcutaneous Nivolumab Injection in Most Solid Tumors
FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.
The American Journal of Managed Care13d
First Subcutaneous Prophylaxis for Hemophilia A and B With Inhibitors Approved by FDA
The approval of concizumab-mtci (Alhemo) injection marks a significant milestone in managing hemophilia A and B with ...
IV drips and doping: What has Max Purcell admitted to, and what’s next?
Australian Max Purcell has been provisionally suspended after using a “prohibited method”. We delve into the case.
FiercePharma3d
Bristol Myers celebrates 10 years of Opdivo with FDA approval for subcutaneous version
Almost exactly 10 years after the FDA’s initial FDA approval for Bristol Myers Squibb’s Opdivo as the first PD-1 inhibitor in ...
Nurse imposter sentenced to seven years
A Canadian woman who posed as a nurse and delivered care to hundreds of patients in British Columbia has been sentenced to seven years in prison. Brigitte Cleroux pleaded guilty in July to assaulting ...
Gene therapy research offers hope for people with chronic kidney disease
Researchers are making strides in improving gene therapies for genetic diseases, particularly chronic kidney disease, using adeno-associated virus, or AAV, vectors. While AAV-based treatments have ...
Managed Healthcare Executive7d
FDA Approves Subcutaneous Opdivo to Treat Solid Tumors
Opdivo Qvantig is the first subcutaneously administered PD-1 inhibitor approved by the FDA. It is expected to be available in ...